Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Non-small Cell Lung Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00948961
What this trial is testing

CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1

Who this might be right for
Advanced Malignancies
Celldex Therapeutics 70
Not applicableStudy completedNCT01067794
What this trial is testing

Chemotherapy in Treating Patients With Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 1,610
Testing effectiveness (Phase 2)UnknownNCT02839954
What this trial is testing

CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor

Who this might be right for
Hepatocellular CarcinomaNon-small Cell Lung CancerPancreatic Carcinoma+4 more
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Early research (Phase 1)Ended earlyNCT03455556
What this trial is testing

Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer

Who this might be right for
Mesothelin PositiveStage III Non-Small Cell Lung Cancer AJCC v7Stage IIIA Non-Small Cell Lung Cancer AJCC v7+2 more
Mayo Clinic 1
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Large-scale testing (Phase 3)UnknownNCT04033354
What this trial is testing

A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC

Who this might be right for
Squamous Non Small Cell Lung Cancer
Shanghai Henlius Biotech 537
Testing effectiveness (Phase 2)Study completedNCT00387322
What this trial is testing

Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors

Who this might be right for
Lung CancerUnspecified Adult Solid Tumor, Protocol Specific
University of California, Davis 42
Testing effectiveness (Phase 2)UnknownNCT01624051
What this trial is testing

A Study Comparing Chemotherapy Dosing Based on Either Standard Body Surface Area or Lean Body Mass in Patients With Advanced Lung Cancer

Who this might be right for
Lung Cancer
AHS Cancer Control Alberta 144
Testing effectiveness (Phase 2)Study completedNCT00994123
What this trial is testing

MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Merrimack Pharmaceuticals 162
Post-approval studies (Phase 4)Study completedNCT04416633
What this trial is testing

Study to Access Safety of Durvalumab in Indian Adult Patients With Locally Advanced NSCLC

Who this might be right for
Unresectable Non-small Cell Lung Cancer (NSCLC)
AstraZeneca 100
Early research (Phase 1)UnknownNCT03274479
What this trial is testing

PBF-1129 in Patients With NSCLC

Who this might be right for
Locally Advanced or Metastatic NSCLC
Palobiofarma SL 18
Testing effectiveness (Phase 2)Study completedNCT00293280
What this trial is testing

Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 42
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Not applicableAvailableNCT06797362
What this trial is testing

Expanded Access Program of Zidesamtinib (NVL-520) for Patients With Advanced ROS1+ NSCLC or Other ROS1+ Solid Tumors

Who this might be right for
Non Small Cell Lung CancerROS1-positive Non-Small Cell Lung Cancer (NSCLC)
Nuvalent Inc.
Large-scale testing (Phase 3)Study completedNCT03191786
What this trial is testing

Atezolizumab Compared With a Single-Agent Chemotherapy in Treatment Naïve Participants With Locally Advanced or Recurrent or Metastatic Non-Small Cell Lung Cancer Who Are Deemed Unsuitable For Platinum-Doublet Chemotherapy

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 453
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07177105
What this trial is testing

Primary Tumor Resection With Sintilimab and Chemotherapy in Advanced NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Jianxing He 118
Testing effectiveness (Phase 2)UnknownNCT05955105
What this trial is testing

ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies

Who this might be right for
Head and Neck CancerCervical CancerEndometrial Cancer+7 more
Innolake Biopharm 200
Testing effectiveness (Phase 2)Study completedNCT00100854
What this trial is testing

Erlotinib With or Without Fulvestrant in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Translational Oncology Research International 108
Not applicableStudy completedNCT02148380
What this trial is testing

Combination of Chemotherapy and Gefitinib as First-line Treatment

Who this might be right for
Non-Small-Cell Lung Cancer
Baohui Han 121
Testing effectiveness (Phase 2)Study completedNCT01836679
What this trial is testing

Chidamide in Combination With Carboplatin and Paclitaxel in Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small-cell Lung Cancer
Chipscreen Biosciences, Ltd. 124
Next Page